Results 81 to 90 of about 1,140,114 (148)

Therapeutics Letter 67

, 2007
Therapeutics Letter 67 discusses the role played by the media as a source of drug therapy information. Conclusions: The media are important for disseminating new therapeutic information and hence quality and completeness of reporting is vital. Frequently
Therapeutics Initiative (University of British Columbia)
core  

Therapeutics Letter 55

, 2005
Therapeutics Letter 55 summarizes five Cochrane systematic reviews that provide clear clinical evidence to direct patient care: corticosteroids for acute traumatic brain injury, fixed dose subcutaneous low molecular weight heparins (LMWH) versus adjusted
Therapeutics Initiative (University of British Columbia)
core  

Author Correction: Targeting HDAC6 to treat heart failure with preserved ejection fraction in mice

Nature Communications
Sara Ranjbarvaziri, Aliya Zeng, Iris Wu, Amara Greer-Short, Farshad Farshidfar, Ana Budan, Emma Xu, Reva Shenwai, Matthew Kozubov, Cindy Li, Melissa Van Pell, Francis Grafton, Charles E MacKay, Xiaomei Song, James R Priest, Gretchen Argast, Mohammad A. Mandegar, Timothy Hoey, Jin Yang   +18 more
doaj   +1 more source

mRNA Therapeutics Beyond Infectious Diseases: Expanding Therapeutic Applications and Future Perspectives. [PDF]

Immun Inflamm Dis
Dejen GM.
europepmc   +1 more source

Author Correction: Safety and pharmacokinetics of the non-hormonal male contraceptive YCT-529. [PDF]

Commun Med (Lond)
Mannowetz N, McCallum SW, Sidhu S, Mena KH, Ruby EP, Castro-Santamaria R, Dodds E, Henderson D, Whitaker G, Wright H, Beaudoin S, Georg GI, Bakshi A.   +12 more
europepmc   +1 more source

Corrigendum to "P53-independent partial restoration of the p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9" [Neoplasia, Volume 23 (2021) 304-325]. [PDF]

Neoplasia
Tian X, Ahsan N, Lulla A, Lev A, Abbosh P, Dicker DT, Zhang S, El-Deiry WS.   +7 more
europepmc   +1 more source

Molecular Response Assessment From Circulating Tumor DNA in Patients With Ovarian Cancer Treated With the WEE1 Inhibitor Azenosertib. [PDF]

JCO Precis Oncol
Jeong J, Ma J, Abed M, Chung H, Kim D, Molden N, Rajendran D, Shim C, Jandial DD, Simpkins F, Meric-Bernstam F, Randall LM, Lackner MR, Harismendy O.   +13 more
europepmc   +1 more source

Target, silence, replace: a review on RNA-based drugs in modern medicine. [PDF]

Front Cell Dev Biol
Mundlia P, Singh SP, Pothal P, Thakur T, Kathuria R, Maurya S, Sharma A, Goel H, Pandey A, Ranawat P, Singh G, Barnwal RP.   +11 more
europepmc   +1 more source

From mRNA stabilisation to mirror life: Biological orthogonality, incremental risk, and anticipatory governance. [PDF]

Front Bioeng Biotechnol
Lean CH, Vincent RM, Lynch KE, Jamrozik E, Jaschke PR.   +4 more
europepmc   +1 more source

mRNA Therapeutics for Skin Rejuvenation: From Aging Atlases to Clinical Translation. [PDF]

Exp Dermatol
Boncimino F, Sol S, Todorova K, Mandinova A.   +3 more
europepmc   +1 more source